Back to Search
Start Over
The CDK 4/6 inhibitor ribociclib has activity in the treatment of inoperable desmoid tumor. A case report.
- Source :
-
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2019 Jun; Vol. 58 (6), pp. 897-900. Date of Electronic Publication: 2019 Mar 25. - Publication Year :
- 2019
- Subjects :
- Adult
Female
Goserelin therapeutic use
Humans
Letrozole therapeutic use
Young Adult
Abdominal Neoplasms drug therapy
Adenomatous Polyposis Coli drug therapy
Aminopyridines therapeutic use
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Cyclin-Dependent Kinase 4 antagonists & inhibitors
Cyclin-Dependent Kinase 6 antagonists & inhibitors
Fibromatosis, Aggressive drug therapy
Protein Kinase Inhibitors therapeutic use
Purines therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1651-226X
- Volume :
- 58
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Acta oncologica (Stockholm, Sweden)
- Publication Type :
- Report
- Accession number :
- 30905251
- Full Text :
- https://doi.org/10.1080/0284186X.2019.1588992